arrow
G

Ge Liu

Xiangtan University
H指数:32
被引数:3,402

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety, tolerability, and immunogenicity of a CpG/Alum adjuvanted SARS-CoV-2 recombinant protein vaccine (ZR202-CoV) in healthy adults: Preliminary report of a phase 1, randomized, double-blind, placebo-controlled, dose-escalation trial

CpG/Alum佐剂SARS-CoV-2重组蛋白疫苗 (ZR202-CoV) 在健康成人中的安全性,耐受性和免疫原性: 1期,随机,双盲,安慰剂对照,剂量递增试验的初步报告

2023-10-262
OAAI
A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta

泛变体mrna-lnp T细胞疫苗可保护HLA转基因小鼠在感染SARS-CoV-2 β 后免于死亡

2023-03-095
OAAI
A potent, broadly protective vaccine against SARS-CoV-2 variants of concern
2022-11-1211
OAAI
Investigating and Resolving Cardiotoxicity Induced by COVID-19 Treatments using Human Pluripotent Stem Cell-Derived Cardiomyocytes and Engineered Heart Tissues

使用人类多能干细胞衍生的心肌细胞和工程心脏组织研究和解决新型冠状病毒肺炎治疗引起的心脏毒性

2022-09-0211
OAAI
Predicted expression of genes involved in the thiopurine metabolic pathway and azathioprine discontinuation due to myelotoxicity
2022-02-204
OAAI